About

Breaking News

A disease-associated gene desert directs macrophage inflammation through ETS2. See our full slide deck review of this key paper!

Breaking News

Guselkumab Demonstrates Superiority Versus Placebo and Ustekinumab in Phase 3 Crohn’s Disease Program

Breaking News

Gastroenterology Launch is now LIVE! Key Historical Publications and Literature Highlights Available Now

Breaking News

Sarcoidosis Awareness Month

Breaking News

Baricitinib in Juvenile Idiopathic Arthritis: An International, Phase 3, Randomised, Double-blind, Placebo-controlled, Withdrawal, Efficacy, and Safety Trial

Breaking News

AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Moderately to Severely Active Crohn's Disease

Breaking News

Galapagos Receives Positive CHMP Opinion for Filgotinib European Label Update Based on Testicular Function Safety Data

Breaking News

FDA Approves Deucravacitinib for Adults with Moderate-to-Severe Plaque Psoriasis

Breaking News

Secukinumab Receives Expanded Approvals in EU for Use in childhood Arthritic Conditions

Breaking News

FDA Approves Baricitinib As First and Only Systemic Medicine for Adults with Severe Alopecia Areata